Status:
COMPLETED
Prevalence of NAFLD in ACS Patients
Lead Sponsor:
Ziekenhuis Oost-Limburg
Conditions:
NAFLD
ACS - Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Addressing CVD risk in patients with NAFLD is the aspect of the disease most amenable to medical management and so improving long-term clinical outcomes. Almost no studies have been done concerning th...
Eligibility Criteria
Inclusion
- \>18 years
- having acute cardiovascular syndrome
- able to understand Dutch
- able to understand the informed consent
Exclusion
- excessive alcohol abuse
- other liver disease
- secondary causes of steatosis
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT05378321
Start Date
February 1 2022
End Date
March 31 2025
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600